Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency'

by Rukmani Krishna on  May 25, 2012 at 7:44 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

According to a new study, magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy considerably earlier than possible through clinical examination.

Women with breast cancer often undergo chemotherapy before the surgery.
 Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency'
Breast MRI 'Better Than Clinical Approach for Predicting Chemotherapy's Efficiency'

Research has revealed that women who receive this treatment, known as 'neoadjuvant chemotherapy', are more likely to achieve breast conservation than those receiving chemotherapy after surgery.

Clinicians have tracked a patient's response to 'neoadjuvant chemotherapy' through clinical measurements of the tumor's size and location.

Contrast-enhanced MRI, also known as Magnetic resonance imaging, offers a promising alternative to the clinical approach through its ability to detect blood vessel formation in tumors, known as angiogenesis.

Angiogenesis is an earlier and more exact marker of tumor response.

"MRI was better than the clinical approach for predicting which patients would go on to have complete tumor response," said Nola M. Hylton, Ph.D., professor of radiology and biomedical imaging at the University of California in San Francisco.

"It gave us great information on early response to treatment," she said.

For the study, researchers analyzed data from 'ACRIN 6657', the imaging component of the multicenter I-SPY TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis) breast cancer trial.

They compared MRI and clinical assessment of 216 female patients ranging between the age from 26 to 68 years undergoing 'neoadjuvant chemotherapy' for stage II or III breast cancer.

MRI sessions were performed before, during and after administration of a chemotherapy treatment.

The researchers then correlated imaging results with subsequent laboratory analysis of surgical samples.

Researchers discovered that MRI size measurements were superior to clinical examination at all time points, with tumor volume change showing the greatest relative benefit at the second MRI exam.

Moreover, MRI was better than the clinical assessment in predicting both complete tumor response and residual cancer burden.

The study reveals that how imaging can play a vital role in characterizing a tumor and monitoring treatment response.

"What we see on imaging helps us define not just the size of the tumor but its biological activity," Hylton said.

"We can observe if the signal increases after contrast injection, and interpret that increase as angiogenic activity. We can also use water diffusion measurements with MRI to provide an indirect reflection of the density of the cells," she added.

Besides this, Hylton and colleagues are currently assessing I-SPY data to see if MRI is better for predicting the likelihood of breast cancer recurrence.

This study has been published online in the journal Radiology.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Mastitis Magnetic Resonance Imaging Chemotherapy Drugs Breasts - Structures and Types Breast Lumps Breast Lumps-Screening Hearing Loss Breast Enhancement Oil Functional Magnetic Resonance Imaging Tumor Lysis Syndrome 

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive